NetApp Inc. vs BIO-TECHNE Corp — how do they compare? NetApp Inc. trades at $161.2 (market cap $31.57B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: NetApp Inc. is far larger — about 2.8× BIO-TECHNE Corp's market cap, and NetApp Inc. pays the higher dividend (1.29%). Which is the better fit depends on your goals.
| NTAP | TECH | |
|---|---|---|
Market Cap | $31.57B | $11.16B |
Sector | Technology | Health |
52-Week High | $181.08 | $72.12 |
52-Week Low | $94.11 | $43.31 |
Enterprise Value | $30.72B | $11.24B |
Dividend Yield | 1.29% | 0.45% |
Trailing returns across standard periods
NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →